Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, Schmoor C, Ohneberg K, Johansen OE, George JT, Hantel S, Bluhmki E, Lachin JM
The FDA has explicitly stated that retatrutide cannot be used in compounding under federal law because it is not a component of an FDA-approved drug and has not been evaluated for safety and efficacy
Laboratory studies suggest that GLP-1 receptor agonists can protect neurons from damage caused by toxic protein aggregates, excitotoxicity, and metabolic stressprocesses implicated in neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease
DSIP is a naturally occurring nonapeptide studied for its ability to engage multiple interconnected biological systems involved in sleep regulation, stress physiology, and neuroendocrine signaling
Here's what we want you to hear: You don't have to keep living like this